PUBLICATIONS  1991-2010

416.  Seeley J, Amurwon J, Foster S: The longitudinal picture: What does it reveal? Published in AIDS and rural livelihoods: Dynamics and diversity in sub-Saharan Africa. (Eds. Anke Niehof, Gabriel Rugalema & Stuart Gillespie). 2010; 13-27.

415.  Excler JL, Rida W,  Priddy F, Gilmour J, McDermott A, Kamali A, Anzala O, Mutua G, Sanders E,  Koff W,  Berkley S, Fast P:  AIDS vaccines and pre-exposure prophylaxis: Is synergy possible? AIDS Res Hum Retroviruses 2010 [Epud ahead of print].  

414.  Hoskins S, Weller I, Jahn A, Kaleebu P, Malyuta R, Kirungi W, Fakoya A, Porter K: Monitoring the progress of the treated population in antiretroviral programmes in low and middle income countries: a comparison of internationally recommended indicators and routine ART programme monitoring reports. AIDS 2010; 24(17): 2603-7.

413.  Maher D,  Smeeth L, Sekajugo J: Health transition in Africa: practical policy proposals for primary care.Bull World Health Organ. 2010; 88(12): 943-8.

412.  Price MA, Wallis C, Lakhi S, Karita E, Kamali A, Anzala O, Sanders EJ, Bekker L, Twesigye R, Hunter E, Kaleebu P, Kayitenkore K, Allen S, Ruzagira E, Mwangome M, Mutua G, Amornkul PN, Stevens G, Pond S, Schaefer M, Gilmour J, (and the IAVI Early Infection Cohort Study Group): Transmitted HIV Type 1 drug resistance among individuals with recent HIV Infection in East and Southern Africa.  AIDS Res Hum Retroviruses 2010 [Epud ahead of print].

411. Shafer LA, White RG, Nsubuga RN, Chapman R, Hayes R, Grosskurth H: The role of the natural epidemic dynamics and migration in explaining the course of the HIV epidemic in rural Uganda: a modelling study. International Journal of Epidemiology 2010; doi: 10.1093/ije/dyq206.

410. Webb EL, Mawa PA, Ndibazza J, Kizito D, Namatovu A, Nampijja M, Muhangi L, Woodburn PW, Akurut H, Mpairwe H, Akello M, Lyadda N, Bukusuba J, Kihembo M, Kizza M, Kizindo R, Nabulime J, Ameke C, Namujju PB, Tweyongere R, Muwanga M, Whitworth AG, Elliott AM: Effect of single-dose anthelmintic treatment during pregnancy on an infant’s response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial. Lancet doi:10.1016/S0140-6736(10)61457-2.

409. Elliott AM, Mawa PA,  Webb EL, Nampijja M, Lyadda N, Bukusuba J, Kizza M, Namujju PB, Nabulime J, Ndibazza J, Muwanga M,  Whitworth JAG: Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus imunization. Vaccine 2010; doi: 10.1016/j.vaccine.2010.10.047

409. Elliott AM,  Mawa PA,  Webb EL, Nampijja M, Lyadda N, Bukusuba J, Kizza M, Namujju PB, Nabulime J, Ndibazza J, Muwanga M,  Whitworth JAG: Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus imunization. Vaccine 2010; doi: 10.1016/j.vaccine.2010.10.047

408.  Seeley J, Ekoru K: Mitigating the impact of the AIDS epidemic on the households and families of older people in rural Uganda: lessons for social protection. Are there lessons for social protection? AJPS 2010; 24(1&2): 113-29.

407. Kinyanda E, Musisi S, Biryabarema C, Ezati I, Oboke H, Walugembe J, Ojiambo-Ochieng R, Were-Oguttu J Levin J, Grosskurth H: War related sexual violence and it’s medical and psychological consequences as seen in Kitgum, Northern Uganda: A cross-sectional study.  BMC Int Health Human Rights 2010; 10(1): 28 [epud ahead of print].  

406.  Hoskins S, Weller I, Jahn A, Kaleebu P, Malyuta R, Kirungi W, Fakoya A, Porter K:  An appraisal of indicators used to monitor the treated population in antiretroviral programmes in low-income countries.  AIDS 2010; 24(17): 2603-7.

405.  Fast PE, Kaleebu P:  HIV vaccines: Current status worldwide and in Africa. AIDS 2010 (Suppl 4): S50-60.

404.  Ramjee G, Kamali A, McCormack S: The last decade of microbicide clinical trials in Africa: From hypothesis to facts. AIDS 2010 (Suppl 4): S40-9.

403.   Biraro S, Mayaud P, Morrow RA, Grosskurth H, Weiss HA: Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from sub-Saharan Africa: A systematic review and meta-analysis Sex Transm Dis. 2010 Aug 12. [Epub ahead of print].

402. Maher D, Waswa L, Baisley K, Karabarinde A, Unwin N, Grosskurth H : Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda. International Journal of Epidemiology 2010; 1-12 (doi: 10.1093/ije/dyq156).

 401.   Lugada E, Levin J, Abang B, Mermin J, Mugalanzi E, Namara G, Gupta S, Grosskurth H, Jaffar S, Coutinho A,  Bunnell R: Comparison of home and clinic based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial.  J Acquir Immune Defic Syndr. 2010; 55(2): 245-52.

400. McCormack S, Ramjee G, Kamali A,  Rees H,  Crook A,  Gafos M,  Jentsch U, (on behalf of the MDP team):  PRO2000 vaginal gel for the prevention of HIV-1 infection (Microbicide Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet 2010; 376 (9749):1329-1337.

399.  Foster S, Nakamanya S, Amurwon J, Kyomuhangi R, Namara G, Amuron B, Wolff B, Jaffar S, Grosskurth H:  The experience of “medicine companions” to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda. AIDS Care 2010; 22(1): 35-43.

398.  McCarthy M, Maher D, Ly A, Ngip AA,  (on behalf of CAAST-Net): Developing the agenda for European Union collaboration on non-communicable diseases research in sub-Saharan Africa.  Health Res Policy Syst. 2010;19(8):13.

397.    Vardas E, Kaleebu P, Bekker L-G, Hoosen A,  Chomba E,  Johnson PR,  Anklesaria P, Birungi J, Barin B,  Boaz M, Cox J, Lehrman J, Stevens G, Gilmour J, Tarragona T, Hayes P, Lowenbein S, Kizito E, Fast P, Heald AE, Schmidt C:  A Phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV-1 vaccine based on adeno-associated virus. AIDS  Res Hum Retroviruses  2010; 26(8):933-42.

396.   Barigye H, Levin J, Maher D, Tindiwegi G, Atuhumuza E, Nakibinge S, Grosskurth H: Operational evaluation of a service for prevention of mother to child transmission of HIV in rural Uganda: - barriers to uptake of single dose nevirapine and the role of birth notification. TMIH 2010: Epub ahead of print.

395.   Lyagoba F, Dunn D, Pillay D, Kityo C, Robertson V, Tugame S, Hakim J, Munderi P, Ndembi N, Gilks C, Yirrell D, Burke A, Kaleebu P,  (on behalf of the DART Virology and Trial Team):  Evolution of drug  resistance during 48 weeks of zidovudine/lamivudine/tenofovir  in the absence of real-time viral load monitoring.  J Acquir Immune Defic Syndr. 2010: Epub ahead of print.

394.   Heng A, Xiang ZQ, Li Y, Zhou DM, Hutnick N, Yuan S, Gray C, Serwanga J, Kaleebu P, Zhou X, Betts M, Ertl HCJ:  Adenovirus-based Vaccines: comparison of Vectors from three families of Adenoviridae.  J Virol 2010 Epud ahead of print.

393.  Barnett T, Seeley J: Response to Wouters et al, March 2010 (Letter to the editor). TMIH 2010 15(8): 958-959.

392. Russell S, Seeley J, Whiteside A: Expanding antiretroviral therapy provision in resource-constrained settings: social processes and their policy challenges. AIDS Care 2010 22 (1): 1-5.

391.   Montgomery CM: The co-production of gender and technology in HIV prevention research: A case study of the Microbicide Development Programme. A PhD dissertation, 2010.

390.  Kamali A, Byomire H, Muwonge C, Bakobaki J, Rutterford C, Okong P, Profy A, Byaruhanga R, Namukwaya S, McCormack S, Grosskurth H, Nunn AJ, Lacey CJ: A randomised placebo-controlled safety and acceptability Trial of PRO2000 vaginal microbicide gel in sexually active women in Uganda. Sex Transm Infect. 2010 86(3): 222-6.

389. Kamali A: What is new in HIV/AIDS research in developing countries? TMIH 2010 15(8): 975-980.

388.  Maher D:  Re-thinking global health sector efforts for HIV and tuberculosis epidemic control: promoting integration of programme activities within a strengthened health system. BMC Public Health 2010 10: 394.

387.   Nobelius A, Kalina B, Pool R, Whitworth J, Chesters J, Power R:  "You still need to give her a token of appreciation": The meaning of the exchange of money in the sexual relationships of out-of-school adolescents in rural southwest Uganda.  J Sex Res. 2010 [Epud ahead of print].

386.  McCormick AL, Goodall RL, Joyce A, Ndembi N, Chirara M, Katundu P, Walker S, Yirrell D, Gilks C, Pillay D, (on behalf of the DART Virology Group and Trial Team): Lack of minority K65R resistant viral populations detected after repeated treatment interruptions of Tenofovir/Zidovudine and Lamivudine in a resource- limited setting. Acquir Immune Defic Syndr 2010 54(2): 215-6.

385. Mayanja B, Todd J,  Hughes P, van der Paal L, Mugisha JO, Atuhumuza E, Tabuga P, Hughes P, Maher D, Grosskurth H: Septicaemia in a population-based HIV clinical cohort in rural Uganda, 1996-2007: incidence, aetiology, antimicrobial drug resistance and impact of antiretroviral therapy. TMIH 2010; 15(6): 697-705.

384. Montgomery C,  Gafos M, Shelley L, Morar NS, Mweemba O, Ssali A, Stadler J, Pool R: Re-framing microbicides acceptability: findings from the MDP 301 trial” Culture, health and Sexuality 2010; doi: 10.1080/13691051003736261.

383. Nobelius AM, Kalina B, Pool R, Whitworth JW, Chesters J, Power R: Sexual and reproductive health information sources preferred by out-of-school adolescents in rural southwest Uganda.Sex Education 2010; 10(1): 91-107.

382. Wakeham K, Harding R, Bamukama D, Levin J, Kissa J, Parkes R, Muzaaya G, Grosskurth H, Lalloo D: Symptom Burden in HIV-Infected Adults at Time of HIV Diagnosis in Rural Uganda. Journal of Palliative Medicine 2010; 13(4): 375-380.

381.  Maher D:  Implications of the global financial crisis for the response to diseases of poverty within overall health sector development: the case of tuberculosis.  TMIH 2010 15(1): 11-17.

380.  Akena DH, Musisi S, Kinyanda E: A comparison of the clinical features of depression in HIV-positive and HIV- negative patients in Uganda. African Journal of Psychiatry 2010; Epud ahead of print.

379.  Nampijja M, Apule B, Lule S, Akurut H, Muhangi L, Elliott AM, Alcock KJ:  Adaptation of Western measures of cognition for assessing 5-year-old semi-urban Ugandan children.  British Journal of Educational Psychology 2010; 80: 15-30.

378.  Maher D, Harries AD: Quality care: a link between clinical and public health approaches to HIV infection in developing countries. TMIH 2010; 15(4): 391-395.

377.  Nalwoga A,  Maher D, Todd J, Karabarinde A, Biraro S, Grosskurth H:  Nutritional status of children living in a community with high HIV prevalence in rural Uganda: a cross-sectional population-based survey. TMIH 2010; 15(4): 414-422.  

376.  Seeley J, Russell S:  Social rebirth and social transformation? Rebuilding social lives after ART in rural Uganda.  AIDS Care 2010; doi: 10.1080/09540121003605054.

375.  Miiro G, Nakubulwa S, Watera C, Munderi P, Floyd S, Grosskurth H: Evaluation of affordable screening markers to detect CD4+ T-cell counts below 200 cells/mul among HIV-1- infected Ugandan adults.  TMIH 2010; Epud ahead of print.

374. Namakoola I, Wakeham K, Parkes-Ratanshi R, Levin J, Mugagga T, Seymour C, Kissa J, Kamali A, Lallo DG:  Use of nail and oral  pigmentation to determine ART eligibility among HIV-infected Ugandan adults.

373. Ndibazza J, Muhangi L, Akishule D, Kiggundu M, Ameke C, Oweka J, Kizindo R, Duong T, Kleinschmidt I, Muwanga M, Elliott AM: Effects of de-worming during pregnancy on maternal and perinatal outcomes in Entebbe Uganda: a randomised controlled trial. Clin Infect Dis. 2010; 50(4):531-40.

372. Maher D, Biraro S, Hosegood V, Isingo R, Lutalo T, Mushati P, Ngwira B, Nyirenda M, Todd J, Zaba B (on behalf of the collaborators in the ALPHA network) Translating global health research aims into action: the example of the ALPHA* (*Analysing Longitudinal Population-based HIV/AIDS data on Africa). TMIH 2010; Epub ahead of pint.

371.  Munderi P, Walker AS, Kityo C, Babiker AG, Ssali F, Reid A, Darbyshire JH, Grosskurth H, Mugyenyi P, Gibbs DM, Gilks CF, (on behalf of the DART/NORA trial team): Nevirapine/Zidovudine/Lamivudine has superior  immunological and virological responses but poorer clinical outcomes in a randomised comparison with Abacavir/Zidovudine/Lamivudine through 48 weeks in HIV-infected Ugandan adults with low CD4 counts. HIV Med. 2010; Epub ahead of print.

370.  Mugyenyi P, Walker AS, Hakim J, Munderi P, (DART trial team): Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomized non-inferiority trial. Lancet 2010; 375(9709):123-31.

369.  Ndembi N, Kaleebu P, Goodall RL., Dunn DT, McCormick A, Burke A, Lyagoba F, Munderi P, Katundu P, Kityo C, Robertson V, Yirrell DL, Walker AS, Gibb DM, Gilks CF, Pillay D (on behalf of the DART Virology Group and Trial Team)  Dynamics of viral rebound and emergence of drug resistance in the absence of  viral load testing: a randomised comparison between zidovudine-lamivudine plus Nevirapine  and Combivir/Nevirapine and zidovudine-lamivudine plus Abacavir. J Infect Dis. 2010; 201(1): 106-13.

368.  Russell S, Seeley J: The transition to living with HIV as a chronic condition: Working to create order and control when on anti-retroviral therapy.  Social Science & Medicine 2010; 70: 375-382.

367. Munderi P: When to start antiretroviral therapy in adults in low-income and middle-income countries: science and practice. Current Opinion in HIV and AIDS 2010; 5:6–11.

366.  Walker AS, Ford D, Gilks CF, Munderi P, Ssali F, Reid A, Katabira E, Grosskurth H, Mugyenyi P, Hakim J, Darbyshire JH, Gibb DM, Babiker AG: Impact of daily cotrimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy; an observational analysis of the DART trial cohort. Lancet 2010; epud ahead of print.

365.  Wakeham K, Parkes-Ratanshi R, Watson V, Ggayi A-B, Khoo S, Lalloo DG: Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans. JAC 2010; 65(2):316-319.

364.  Maher D, Sekajugo J, Harries AD, Grosskurth H; Research needs for an improved primary care response to chronic non-communicable diseases in Africa. TMIH 2010; 15 (2): 176–181.

360. Nyanzi S, Nyanzi-Wakholi B, Kalina B: Male Promiscuity. Men and Masculinities 2009;2(1):73-89.

359. Wolff B, Mbonye M, Coutinho A, Amuron B, Nkabala R, Jaffar S, Grosskurth H:   High levels of psycho- social readiness for ART in an African population at the onset of treatment.  SAHARA Journal 2009; 6(4): 188-194.

358.   Seeley J, Dercon S, Barnett T: The effects of HIV/AIDS on rural communities in East Africa: A twenty year perspective. TMIH 2009: doi: 10.1111/j.1365-3156.2009.02458.x.

357.     Jaffar S, Amuron B, Foster S, Birungi J, Levin J, Namara G, Nabiryo C, Ndembi N, Kyomuhangi R, Opio A, Bunnell R, Tappero JW, Mermin J, Coutinho A, Grosskurth H, (on behalf of the Jinja trial team): Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 2009 doi:10.1016/S0140-736(09)61674-3.

356.     Ruzagira E, Abaasa A, Levin J,  Bahemuka U, Bwanika A, Amornkul PN, Price MA, Grosskurth H, Kamali A: Haematological and biochemistry laboratory abnormalities associated with splenomegaly in symptomatic adults in Masaka, Uganda: implications for HIV biomedical prevention trials. TMIH doi:10.1111/j.1365-3156.2009.02428.x.

355. Steen R, Wi TE, Kamali A, Ndowa F: Control of sexually transmitted infections and prevention of HIV transmission: mending a fractured paradigm. WHO Bulletin 2009;87: 858-865.

354.   UNAIDS Reference Group on Estimates, Modelling, and Projection: Working Group on Measuring Concurrent Sexual Partnerships.  HIV: consensus indicators are needed for concurrency. (Comment).  Lancet 2009; 375 (9715): 621-622. (Dermot is a member of the working group).

353.  Kinyanda E, Woodburn P, Tugumisirize J, Kagugube J, Ndyanabangi S, Patel V: Poverty, life events and the risk for depression in Uganda. Soc Psychiatry & Psychiatric Epidemiol 2009; doi 10.1007/s00127-009-0164-8.  

352. Maher D:  Food incentives and completion of tuberculosis treatment. (Editorial) British Medical Journal  2009; 339: 1094-5.

351.     Woodburn PW, Muhangi L, Hillier S, Ndibazza J, Namujju P, Kizza M, Ameke C, Omoding NE, Booth M, Elliott AM:  Risk factors for helminth, malaria and HIV infection in pregnancy in Entebbe, Uganda.  PLoS Negl Trop Dis. 2009; 3(6):e473.

350.     Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL, Wrin T, Simek MD, Fling S, Mitcham JL, Lehrman JK, Priddy FH, Olsen OA, Frey SM, Hammond PW, Protocol G investigators (for MRC/UVRI: Serwanga J, Miiro G ): Broad and potent neutralising antibodies from an African donor reveal a new HIV-1 vaccine target.   Science 2009; 326(5950):285-9.

349. Maher D, Harries AD, Zachariah R, Enarson D: A global framework for action to imptrove the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Public Health 2009; 9:355

348. Seeley J, Tumwekwase G, Groskurth H: Fishing a Living but Catching HIV: AIDS and Cahnging Patterns of the Oranisation of Work in Fisheries in Uganda. Anthropology of Work Review 2009; 30(2):66-76.

346. Maher D: Standardized interventions in interaction in health : Procrustes, where are you now?Tropical Medicine and International Health 2009; 14(10)1162-1164.

344. Amuron B, Namara G, Birungi J, Nabiry C, Levin J, Grosskurth H, CoutinhoA, Jaffar S, : Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda.BMC Public Health 2009;9(290)doi:10,1186/1471-2458-9-290.

343.   Musisi S, Kinyanda E :  Emotional and behavioural disorders in HIV seropositive adolescents in urban Uganda. East Afr Med J. 2009; 86(1): 16-24.

342.   Tweyongyere R, Mawa PA, Emojong NO, Mpairwe H, Jones FM, Duong T, Dunne DW, Vennervald BJ, Katunguka-Rwakishaya E, Elliott AM:  Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised,   placebo-controlled trial. BMC Infectious Diseases 2009, 9:32

341. Marston M, Slaymaker E, Cremin I, Floyd S, McGrath N, Kasamba I, Lutalo T, Nyirenda M, Ndyanabo A, Mupambireyi Z, Zaba B: Trends in marriage and time spent single in sub- Saharan Africa, a comparative analysis of six population- based cohort studies and nine Demographic and Health Surveys. STI 2009; (Suppl. I): i64-i71. doi: 10.1136/sti. 2008. 034249.

340.  Slaymaker E, Bwanika JB, Kasamba I, Lutalo T, Maher D, Todd J: Trends in age at first sex in Uganda: evidence from Demographic and Health Survey data and longitudinal cohorts in Masaka and Rakai. STI 2009; (Suppl. I): i12-i19. doi:10.1136/sti.2008.034009.

339.  Biraro S, Shafer LA, Kleinschmidt I, Wolff B, Karabalinde A, Nalwoga A, Musinguzi J, Kirungi W, Opio A, Whitworth J, Grosskurth H: Is sexual risk taking behaviour changing in rural southwest Uganda ? Behaviour trends in a rural population cohort 1993-2006. STI 2009; (Suppl. I): i3-i11. doi: 10.1136/sti. 2008.033928.

338.  Todd J, Cremin I, McGrath N, Bwanika J-B, Wringe A, Marston M, Kasamba I, Mushati P, Lutalo T, Hosegood V, Zaba B:  Reporting number of sexual partners: comparison of data from four African longitudinal studies.  STI 2009; 85(Suppl. I): i72-i80. doi: 10.1136/sti.2008.033985.

337. Wringe A, Cremin I, Todd J, McGrath N, Kasamba I, Herbst K, Mushore P, Zaba B, Slaymaker E:Comparative assessment of the quality of age-at- event reporting in three HIV cohort studies in sub- Saharan  Africa. STI 2009; 85(Suppl. I):i56-i63. doi:10.1136/sti.2008.033423. 

336.   Miiro G, Todd J, Mpendo J, Watera C, Munderi P, Nakubulwa S, Kaddu I, Rutebarika D, Grosskurth H: Reduced morbidity in the first year after initiating highly active anti-retroviral therapy (HAART) amongUgandan adults. TMIH 2009; Epud ahead of print.

335.   Karita E, Ketter N, Price MA, Kayitenkore K, Kaleebu P, Nanvubya A, Anzala O, Jaoko W, Mutua G, Ruzagira E, Mulenga J, Sanders EJ, Mwangome M, Allen S, Bwanika A, Bahemuka U, Awuondo K, Omosa G, Farah B, Amornkul P, Birungi J, Yates S, Stoll-Johnson L, Gilmour J, Stevens G, Shutes E, Manigart O, Hughes P, Dally L, Scott J, Stevens W, Fast P, Kamali A.  CLSI-derived haematology and biochemistry  reference  intervals for healthy adults in eastern and southern Africa. PLoS ONE  2009;4(2):e4401.  

334.  Nakibinge S, Maher D, Katende J, Kamali A, Grosskurth H, Seeley J:  Community engagement in health research: two decades of experience from a research project on HIV in rural Uganda. TMIH  2009; 14 (2): 190-195.

333. Todd J, Lutalo T, Kaleebu P: Response to Mermin et al: Estimating incidence of HIV infection in Uganda. Letter to the editor.  JAMA 2009; 301(2): 159-160

332.  Serwanga J, Shafer LA, Pimego E, Auma B, Watera C, Rowland S, Yirrell DL,  Pala P, Grosskurth H, Whitworth J, Gotch F, Kaleebu P:  Host HLA B*allele-associated multi-clade gag T-cell recognition correlates with slow HIV disease progression in Antiretroviral therapy-naive Ugandans. PLoS One 2009; 4(1): e4188. doi:101371/journal.pone.0004188. 


331. Seeley J, Wolff B, Kabunga E, Tumekwase G, Grosskurth H: “This is where we’ve buried our sons’: people of  Advanced old age coping with the impact of the AIDS epidemic in a resource- poor setting in rural Uganda. Aging & Society  2009; 29: 115-134.

330. Ruzagira E, Wandiembe S,  Bufumbo L, Levin J, Price MA, Grosskurth H, Kamali A: Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda.TMIH  2009; 14(2): 1-8.

329.  Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee D, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC:  HIV-1 elite neutralizers: Individuals with broad and potent neutralizing activity identified using a high throughput neutralization assay together with an analytical selection algorithm.  J Virol. 2009; Epub ahead of print

328. Pala P, Gomez-Roman VR, Gilmour J, Kaleebu P: An African perspective on mucosal immunity and HIV-1. Mucosal Immunol. 2009; Epub ahead of print.

327. Nyanzi-Wakholi B, Lara AM, Watera C, Munderi P, Gilks C, Grosskurth H (on behalf of the DART Trial Team) The role of HIV testing, counselling, and treatment in coping with HIV/AIDS: a qualitative analysis. AIDS Care 2009; 21(7): 903-908.

326.  Woodburn PW, Muhangi L, Hillier S, Ndibazza J, Namujju P, Kizza M, Ameke C, Omoding NE, Booth M, Elliott AM: Risk factors for helminth, malaria and HIV infection in pregnancy in Entebbe, Uganda.  PLoS Negl Trop Dis. 2009; 3(6):e473.

325. Anzala O, Sanders J, Kamali A, Katende M, Mutua GN, Ruzagira E, Stevens G, Simek M, Price M: Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing. East African   Medical Journal 2008; 85(10): 500-504. 

324.  Boaz MJ, Hayes P, Tarragona T, Seamons L, Cooper A, Birungi J, Kitandwe P, Semaganda A, Kaleebu P, Stevens G, Anzala O, Farah B, Ogola S, Indangasi J, Mhlanga P, Van Eeden M, Thakar M, Pujari A, Mishra S,Goonetilleke N, Moore S, Mahmoud A, Sathyamoorthy P, Mahalingam J, Narayanan PR, Ramanathan VD, Cox JH, Dally L, Gill DK, Gilmour J:  Measuring T-cell immunity in HIV vaccine clinical trials: PBMC and ELISPOT assay proficiency concordance in laboratories from 3 continents. Clin Vaccine Immunol. 2008; Epub ahead of print.

323.  Kaleebu P, Abimiku A, El-Halabi S, Koulla-Shiro S, Mboup S, Mugerwa R, Nkengasong J, Toure-Kane C,Tucker T, Wassenaar D, Williamson C, Wolday D: African AIDS Vaccine Programme for a coordinated and collaborative vaccine development effort on the continent. PloS Medicine 2008; 5(12): e236

322. Cohen MS, Kaleebu P, Coates T: Prevention of the sexual transmission of HIV-1: preparing for success. A  review article. JInt  AIDS  Soc. 2008; 11 (1): 4.

321.  Tweyongyere R, Mawa PA, Ngom-Wegi S, Ndibazza J, Duong T, Vennervald BJ, Dunne DW, Katunguka- Rwakishaya E, Elliott AM.  Effect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomised, placebo-controlled trial. J Infect Dis. 2008; Nov 4. (Epub ahead of print).

320.  Stöhr W, Walker AS, Munderi P, Tugume S, Gilks CF, Darbyshire JH, Hakim J,  on behalf of the DART Trial. Estimating glomerular filtration rate in HIV-infected adults in Africa: Comparison of Cockcroft-Gault and  MDRD formulae. Antivir Ther. 2008; 13(6): 761-70.   

319.   Hillier SD, Booth M, Muhangi L, Nkurunziza P, Khihembo M, Kakande M, Sewankambo M, Kizindo R, Kizza  M, Muwanga M, Elliott AM: Plasmodium falciparum and helminth co-infection in a semi-urban population of   pregnant women in Uganda. J Infect Dis. 2008; 198(6): 920-7.

318.   Temple B, Ayakaka I, Ogwang S, Nabanjja H, Kayes S, Nakubulwa S, Worodria W, Levin J, Joloba M, Okwera A, Eisenach KD, McNerney R, Elliott AM, Smith PG, Mugerwa RD, Ellner JJ, Jones-Lopez EC: Rate and amplification of drug resistance among previously treated patients with Tuberculosis in Kampala, Uganda. Clin Infect Dis. 2008; 47(9): 1126-34.

317.   Lang T, Chilengi R, Noor RA, Ogutu B, Todd JE, Kilama WL, Targett GA: Data safety and monitoring boards for African clinical trials. Trans R Soc Trop Med Hyg. 2008; 102 (12): 1189-94.

315.  Lara AM, Nyanzi-Wakholi B, Kasirye A, Munderi P, Watera C, Lalloo DG, Alan Haycox A, Gilks CF, rosskurth  H:  Utility assessment of HIV/AIDS related health states in HIV infected Ugandans. AIDS 2008; 22(suppl 1): S123-S130.

314.   Seeley J, Biraro S, Shafer LA, Nasirumbi P, Foster S,  Whitworth J, Grosskurth H: Using in-depth qualitative data to enhance our understanding of quantitative results regarding the impact of HIV and AIDS on families and households in rural Uganda. Soc Sci Med. 2008; 67(9): 1434-46. 

313.   Shafer LA, Biraro S, Nakiyingi-Miiro J, Kamali A, Ssematimba D, Ouma J, Ojwiya A,  Hughes P,  Van der Paal L, Whitworth J, Opio A, Grosskurth H: HIV prevalence and incidence are no longer falling in Southwest Uganda: Evidence from a Rural Population Cohort 1989 – 2005.  AIDS 2008; 22 (13): 1641-9.

312.   Wandel S, Egger M, Rangsin R, Nelson KE, Costello C, Lewden C, Lutalo T, Ndyanabo A, Todd J, van der Paal L, Minga A, Zwahlen M: Duration from sero-conversion to eligibility for antiretroviral therapy and  from  ART  eligibility to death in adult HIV-infected patients from low and middle income countries: collaborative analysis of  prospective studies. Sex. Transm. Infect. 2008; 84(Suppl. I): i31-i36. doi: 10.1136/sti.2008.029793

311.  DART trial Team:  24 week safety and tolerability of Nevirapine versus Abacavir in combination with  Zidovudine/Lamivudine as first-line antiretroviral therapy:  A randomised double-blind trial (NORA). TMIH 2008; 13 (1): 6-16.   

310.  The DART Trial Team:  Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD<200 cells/mm3. AIDS 2008; 22: 237-47.

309.  Hjelmeland H, Knizek BL, Kinyanda E, Musisi S, Nordvik H, Svarva K. Suicidal behaviour as communication in a cultural context: A comparative study between Uganda and Norway. CRISIS 2008; 29(3): 137-144.

308. Muyingo SK, Walker AS, Reid A, Munderi P, Gibb DM, Ssali F, Levin J, Katabira E, Gilks C, Todd J; the DART TrialTeam: Patterns of Individual and Population-Level Adherence to Antiretroviral Therapy and Risk Factors for  Poor Adherence in the First Year of the DART Trial in Uganda and Zimbabwe.  J Acquir Immune Defic Syndr. 2008 ; 48(4):468-475.

307.  Jaoko W, Nakwagala FN, Anzala O, Manyonyi GO, Birungi J, Nanvubya A, Bashir F, Bhatt K, Ogutu H,  Wakasiaka S, Matu L, Waruingi W, Odada J, Oyaro M, Indangasi J, Ndinya-Achola J, Konde C, Mugisha E, Fast P, Schmidt C, Gilmour J, Tarragona T, Smith C, Barin B, Dally L, Johnson B, Muluubya A, Nielsen L, Hayes P, Boaz M, Hughes P, Hanke Tomas, McMichael A, Bwayo J, Kaleebu P:  Safety and Immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa. Vaccine 2008; 26(22):2788-95.

306.  Liebling-Kalifani H, Ojiambo-Ochieng R,  Marshall A, Were-Oguttu J, Musisi S, Kinyanda E: Violence against Women in Northern Uganda: The Neglected Health Consequences of War.  JIWS 2008; 9 (3): 174-192.

305. Ndembi N, Lyagoba F, Nanteza B, Kushemererwa G, Serwanga J, Katongole-Mbidde E, Grosskurth H,  Kaleebu P. Anti-retroviral drug resistance surveillance among newly diagnosed women attending antenatal clinic in Entebbe, Uganda. AIDS Res & Human Retroviruses, 2008; 24(6): 889-894.

304.  Stevens W, Kamali A, Karita E,  Anzala O, Sanders EJ, Jaoko W,  Kaleebu P, Mulenga J, Dally L, Fast P,      Gilmour J, Farah B, Birungi J, Hughes P, Manigart O, Stevens G, Yates S, Thomson H, von Lieven A, Krebs  M, Price MA, Stoll-Johnson L, Ketter N: Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials. PLoS One 2008; 3(4): e2043.

303. Todd J, Corran P: Statistical consideration of the role of potential confounders on the association between immunological responses and disease. Parasite Immunol. 2008; 30(5): 268-70.

302. Kizito D, Woodburn PM, Kesande B, Ameke C, Nabulime J, Muwanga M, Grosskurth H, Elliott AM:  Uptake of  HIV and syphilis testing by pregnant women and their male partners in a programme for Prevention of Mother-to-Child HIV transmission in Uganda. Trop. Med. Int.  Health. 2008; 13(5): 680-2.

301. Mugisha JO, Shafer LA,  Van der Paal L, Mayanja BN, Eotu H, Hughes P, Whitworth JAG, Grosskurth H: Anaemia in a rural Ugandan HIV-1 infected cohort: Prevalence at  enrolment, incidence, diagnosis and  associated factors. TMIH 2008; 13 (6): 788-794.

300. Hallett, TB, Zaba, B, Todd, J, Lopman, B, Wambura, M, Biraro S, Gregson, S, Boerma JT: Estimating Incidence from Prevalence: Methods and Validation.  PLoS 2008; 5(4): e80.

299. Reid AJ, Stohr W, Walker AS, Williams IG, kityo C, Hughes P, Kambugu A, Gilks CF, Mugyenyi P, Munderi   P, Hakim J, Gibb DM, (on behalf of the DART team):  Severe renal dysfunction and risk factors associated with  renal impairment in adults with HIV infection in Africa initiating Antiretroviral Therapy. CID 2008; 46: 1271- 1281.

298. Jaffar S, Amuron B, Birungi J, Namara G, Nabiryo C, Coutinho A, Grosskurth H:  Integrating research into routine service delivery in a antiretroviral treatment programme: lessons learnt from a cluster randomised trial comparing different strategies of HIV care in Jinja, Uganda. TMIH 2008; 13(6): 1-6.

297. Rwemisisi J, Wolff B, Coutinho A, Grosskurth H, Whitworth J: ‘What if they ask how I got it ?’ Dilemmas of parental disclosure and testing children for HIV in Uganda. Research letter. Health Policy Plan 2008; 23 (1): 36-42. Copy has been ordered from HPP, June 2008 (BW)

296. Senkaali D, Kebba A, Shafer LA, Campbell G Loret E, Van der Paal L, Grosskurth H, Yirell D, Kaleebu P: Tat specific binding IgG and disease progression in HIV-1 infected Ugandans.  AIDS Res & Human Retroviruses
2008; 24(4): 587-94.

295.  Mpairwe H, Muhangi L, Ndibazza J, Tumusiime , Muwanga M, Rodrigues L, Elliott A: Skin prick test reactivity to common allergens among women in a peri-urban area in Uganda. Trans Roy Soc Trop Med 2008; 102: 367-373

294.     Hjelmeland H, Akotia C, Owens V, Knizek BL, Nordvik H, Schroeder R, Kinyanda E.  Self-reported suicidal behaviour and attitudes towards suicide and suicide prevention among psychology students in Ghana, Uganda and Norway. CRISIS 2008; 29 (1): 20-31.

293.     Jaffar S, Birungi  J, Grosskurth H, Amuron B, Namara G, Nabiryo C, Coutinho A.    Use of WHO clinical stage for assessing patient eligibility to antiretroviral therapy in a routine health service setting in Jinja, Uganda. AIDS Research and Therapy 2008;  5 (4): doi: 10.1186/1742-6405-5-4.

292.     DART trial Team:  24 week safety and tolerability of Nevirapine versus Abacavir in combination with Zidovudine/Lamivudine as first-line antiretroviral therapy:  A randomised double-blind trial (NORA). TMIH 2008; 13 (1): 6-16.   

289. Musisi S, Kinyanda E, Nakasujja N, Nakigudde J:  A comparison of the behavioural and emotional disorders of  primary  school-going orphans  and non-orphans in Uganda. African Health Sciences 2007; 7(4): 202-213.

 288. Watera C, Todd J, Mutonyi G, Miiro G, Mpendo J, Hughes P, Nakiyingi-Miiro J, Whitworth J, Mermin J,   Grosskurth H: Effects of cotrimoxazole on haematological parameters in HIV infected adults in a community based  clinic in Entebbe, Uganda.  JAIDS 2007; 46 (3): 369-371.

287.   Marston M, Todd J, Glynn JR, Nelson K, Rangsin R, Urassa M, Biraro S, Van der Paal L, Sonnenberg P, Zaba B. Estimating “net” HIV-related mortality and the importance of background mortality rates. AIDS 2007; 21 (suppl. 6): S65-71.

286.   Zaba B, Marston M, Crampin A, Isingo R, Biraro S, Barninghausen T, Lopman B, Lutalo     T, Glynn J, Todd J.  Age-specific mortality patterns in HIV infected individuals: a comparative analysis of African community study data. AIDS 2007; 21 (suppl. 6): S87-96.

285. Todd J, Glynn JR, Marston M, Lutalo T, Biraro S, Mwita W, Suriyanon, Rangsin R, Nelson K, Sonnenberg P, Fitzgerald D, Zaba B. Time from HIV sero-conversion to death: A collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy.   AIDS 2007; 21 (suppl. 6): S55-63.

284. Van der Paal L, Shafer LA, Todd J, Mayanja B, Whitworth J, Grosskurth H. HIV-1 disease progression and mortality before the introduction of  highly active antiretroviral therapy in rural Uganda. AIDS 2007; 21 (suppl. 6): S21-29.

283.  Campbell GR, Senkaali D, Watkins J, Esquieu D, Opi S, Yirrell DL, Kaleebu P, Loret E. Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties.  Vaccine 2007; 25 (50); 8441-8447.

282. Vernazza C R,  Majanya B N, Mugisha JO,  Van der Paal L, Young CJ, Robinson PG. The value of training doctors in the diagnosis of oral manifestations of HIV.  Journal of Disability and Oral health 2007; 8 (2): 81-85.

281.   Vernazza C R,  Majanya B N, Mugisha JO,  Van der Paal L, Young CJ, Robinson PG. The value of training doctors in the diagnosis of oral manifestations of HIV.  Journal of Disability and Oral health 2007; 8 (2): 81-85.

280.  Tann CJ, Kizza M, Morison L, Mabey D, Muwanga M, Grosskurth H, Elliott AM. Use of antenatal services and  delivery care in Entebbe, Uganda: a community based survey. BMC  Pregnancy and Child Birth 2007; 7 (23) doi: 10.1186/1471-2393-7-23.

279.  Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, temu F, Laing R. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 2007; 19 (5): 658-65. 

278.  Herbeck JT, Lyogoba F, Moore SW, Shindo N, Biryahwaho B, Kaleebu P, Mullins JI. Prevalence and genetic diversity of HIV type 1 subtypes A and D in women attending antenatal clinics in Uganda. AIDS Res & Human Retroviruses 2007; 23 (5): 755-760.

277. Van der Paal L, Shafer LA, Mayanja BN, Whitworth JAG, Grosskurth H. Effect of pregnancy on HIV disease  progression and survival among women in rural Uganda. Trop Med Int Hlth 2007: 12(8): 920-928. 

276. Muhangi L, Woodburn P, Omara M, Omoding N, Kizito D, Mpairwe H, Nabulime J, Ameke C, Morison LA, Elliott AM. Associations between mild-to-moderate anaemia in pregnancy and helminth, malaria and HIV infection in Entebbe, Uganda. Transact Royal Soc of Trop Med Hyg  2007; 101: 899-907.

275.  White RG, Cooper BS, Kedhar A, Orroth KK, Biraro S, Baggaley RF, Whitworth J, Korenromp EL, Ghani A, Boily M-C, Hayes RJ. Quantifying HIV transmission due to contaminated injections. PNAS 2007; 104 (23):794-9799. 

274. Biraro S, Morison L, Nakiyingi J, Whitworth J, Grosskurth H. Risk factors for HIV infection amongst children: The role of vertical transmission and health care related factors in HIV infection in children: a community study in rural Uganda. JAIDS 2007; 44 (2):222-8. 

270.   Kebba A, Imami N, Bugembe-Lule D, Senkaali D, Kaleebu P, Grosskurth H, Gotch F. Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials. Pharmacogenomics. 2007; 8(4): 409-414.

269.     Elliott AM, Kizza M, Quigley MA, Ndibazza J, Nampijja M, Muhangi L, Morison L, Namujju PB, Muwanga M, Kabatereine N, Whitworth J.  The impact of helminths on the response to immunisation and on the incidence of infection and disease in childhood in Uganda: design of a randomised, double-blind, placebo-controlled, factorial trial of de-worming interventions delivered in pregnancy and early childhood. Clinical Trials November 2007; 4: 42-57

268.  Yirrell DL, Wright E, Shafer LA, Campbell E, Van der Paal L, Kaleebu P, Grosskurth H, Whitworth J. Association between active GBV-C (hepatitis G) infection and HIV-1 disease in Uganda. Int J STD and AIDS 2007; 18: 244-249.

267.  Cooke GS, Tosh K, Ramaley PA, Kaleebu P, Zhuang J, Nakiyingi JS, Watera C, Gilks CF, French N, Whitworth JAG and Hill AVS. A  polymorphism reducing RANTES expression is associated with protection from death in HIV-positive Ugandans. JID 2006; 194: 666-9.

266.   Gale CV, Yirrell DL, Campbell E, Van der Paal L, Grosskurth H, Kaleebu P. Genotypic variation in the polgene of HIV-1 type 1 in an antiretroviral treatment-naive population in rural southwestern Uganda. AIDS Res Hum Retroviruses 2006; 22(10): 985-92.

265.   Hewitt K, Steketee R, Mwapasa V, Whitworth J, French N. Interactions between HIV and malaria in non-pregnant adults: evidence and implications. Review. AIDS 2006; 20: 1993-2004

264.   Watera C, Whitworth JAG, Muwonge R, Todd J, Nakiyingi J, Brink A, Miiro G, Antvelink L, Kamali A, French N and Mermin J. Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1- infected adults attending an HIV/AIDS clinic in Uganda.J AIDS 2006; 42(3): 373-8.

263.   Barigye H, Roux P, Adams V: Clinical assessment of children. Management of clinical conditions in children. Integartion of palliative care with ART in children. 3 chapters in: Gwyther L, Merriman A, Seburiya L, Schietinger H (editors): A clinical guide to supportive and palliative care for HIV/AIDS in Sub-Saharan Africa. Foundation for Hospices in Sub-Saharan Africa, 2006 edition.  http://www.fhssa.org/i4a/pages/index.cfm?pageid=1

262.   Ssali F, Stöhr W, Munderi P, Reid A, Walker AS, Gibb DM, Mugyenyi P, Kityo C, Grosskurth H, Hakim J, Byakwaga H, Katabira E, Darbyshire JH, Gilks C on behalf of the DART Trial Team. Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV Infection within the DART Trial. Antiviral Therapy 206; 11: 741 – 749

261.   Wolff B, Busza J, Bufumbo L, Whitworth J. Women who fall by the roadside: gender, risk and alcohol in rural Uganda. Addiction 2006; 101:1277-1284. 

260.   Brown M, Mawa P, Kaleebu P, Elliott A. Helminths and HIV infection: epidemiological observations on immunological hypotheses. Parasite Immunology 2006; 28:613-623

259.   Tann CJ, Mpairwe H, Morison L, Nassimu K, Hughes P, Omara M, Mabey D, Muwanga M, Grosskurth H, Elliott A. Lack of effectiveness of syndromic management in targeting vaginal infections in pregnancy in Entebbe, Uganda. STI. Sex Transm Infect 2006; 82: 285-289

258. French N, Kaleebu P, Pisani E and Whitworth JAG. Human Immunodeficiency Virus (HIV) in developing countries. Review. Annuals of Tropical Medicine and Parasitology 2006; 100: 433-454   

257. White R. Variability in the effectiveness of STI treatment interventions to prevent HIV transmission in Eastern and Southern Africa. PhD thesis June 2006. 216 pages.

256.  DART Virology Group and Trial Team.  Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa.  AIDS 2006, 20:1391 – 1399

255.   Brown M, Miiro G, Nkurunziza P, Watera C, Quigley MA, Dunne DW, Whitworth JAG, Elliott AM.  Schistosoma mansoni, nematode infections and progression to active tuberculosis among HIV-1-infected Ugandans.  American Journal of Tropical Medicine and Hygiene, 2006, 74:819-25  

254.  Pool R, Kamali A, Whitworth JAG. Understanding sexual behaviour change in rural southwest Uganda: A multi-method study. AIDS Care 2006; 18: 479-488

253.   Terris-Prestholt F, Kumaranayake L, Foster S, Kamali A, Kinsman J, Basajja V, Nalweyso N, Quigley M, Kengeya-Kayondo, Whitworth J. The role of community acceptance over time for costs of HIV and STI prevention interventions: Analysis of the Masaka Intervention Trial, Uganda, 1996-1999. Sexually Transmitted Diseases. Sex Transm Dis. Oct Supp 2006; 33: S111 – S 116

252.   Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73-84

251. Miiro G, Kayhty H, Watera C, Tolmie H, Whitworth JAG, Gilks CF, French N. Conjugate pneumococcal vaccine in HIV-infected Ugandans and effect of past polysaccharide vaccine receipt. Journal of Infectious Diseases 2005; 192: 1801-5

250. Robinson PG, Nalweyiso N, Busingye J and Whitworth JAG. Subjective dental impacts of caries and fluorosis in rural Ugandan children. Community Dental Health 2005; 22: 231-6

249.  Bakobaki J, Lacey C, Bukenya M, Nunn A, McCormack S, Byaruhanga R, Okong P, Namukwaya S, Grosskurth H, Whitworth J. A randomised controlled safety and acceptability trial of dextrin sulphate vaginal microbicide gel in sexually active women in Uganda. In press, AIDS 2005; 19: 2149-56.

248.   Pickering JM, Whitworth JAG, Hughes P, Kasse M, Morgan D, Mayanja B, Van der Paal L and Mayaud P. Aetiology of sexually transmitted infections and response to syndromic treatment in southwest Uganda. Sexually Transmitted Infections 2005; 81: 488-93

247.  Elliott AM, Namujju PB, Mawa PA, Quigley MA, Nampijja M, Nkurunziza PM, Belisle JT, Muwanga M, Whitworth JAG.  A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to bacille Calmette-Guerin (BCG) immunisation. BioMed Central Infectious Diseases 2005; 5:115

246. Gysels K, Pool R, Nyanzi S. The adventures of the Randy Professor and Angela the Sugar Mummy: Sex in fictional serials in Ugandan popular magazines. AIDS Care, November 2005; 17: 967-977

245.   Elliott A, Mpairwe H, Quigley M, Nampijja M, Muhangi L, Oweka-Onyee J, Muwanga M, Ndibazza J, Whitworth JAG: Helminth infection during pregnancy and development of  infantile eczema.  JAMA 2005; 294: 2032 – 2034

244. Whitworth J. Malaria and HIV. Insite Knowledge Base Chapter 2005. http://hivinsite.ucsf.edu/InSite?page= kb-05-04-04]

 243. Jacobs B, Pool R, Whitworth J.  Incorporating drug shops in the management of sexually transmitted diseases: suggestions from a study in Uganda. International Journal of STD and AIDS 2005; 16: 518-519  

242. Quigley M, Hewitt K, Mayanja B, Eotu H, Ojwiya A, Morgan D, Whitworth J. The effect of malaria on mortality in a cohort of HIV-infected Ugandan adults. Tropical Medicine and International Health 2005; 10: 894-900

241.  Kebba A, Stebbing J, Rowland S, Ingram R, Agaba J, Kaleebu P, Imami N, Gotch F. Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1 sero-negative subjects. Journal of Leukocyte Biology 

240.  De Walque D, Nakiyingi J, Busingye J and Whitworth JAG. Changing association between schooling levels and HIV-1 infection over 11 years in a rural population cohort in south-west Uganda. Trop Med Intern Health 2005; 10: 993-1001

239.  Diaz T, Loth G, Whitworth J, Sutherland D. Surveillance methods to monitor the impact of HIV therapy programmes in resource-constrained countries. AIDS 2005; 19 (supplement 2): S31-S37.

238.  Tann C, Kiggundu M, Ayiko B, Mabey D, Muwanga M, Whitworth J, Elliott A. Incidence and consequences of congenital abnormalitites amongst hospital-born infects in Entebbe, Uganda. Archives of Disease in Childhood 2005; 90 (supplement II): A9-A10.

237.  Mpairwe H, Muhangi L, Namujju PB, Kisitu A, Tumusiime A, Muwanga M, Whitworth JAG, Onyango S, Biryahwaho B, Elliott AM. HIV risk perception and prevalence in a Program for Prevention of Mother-to-Child HIV transmission: Comparison of women who accept VCT and those tested anonymously. Journal of AIDS 2005. JAIDS 39: 354-358

236. Zaba B, Whitworth J, Marston M, Nakiyingi J, Ruberantwari A, Urassa M, Issingo R, Mwaluko G, Floyd S, Nyondo A, Crampin M. HIV and mortality of mothers and children: Evidence from cohort studies in Uganda, Tanzania and Malawi. Epidemiology 2005; 16: 275 - 280

235.  Brown M, Mawa PA, Bukusuba J, Watera C, Whitworth JAG, Dunne DW, Elliott AM. Treatment of schistosomiasis increases helminth-specific type 2 cytokines and HIV-1 viral loads in co-infected Ugandan adults. JID 2005; 191: 1648-1657

234. Jaffar S, Govender T, Garrib A, Welz T, Grosskurth H, Smith P, Whittle H, Bennish M: Antiretroviral treatment in resource-poor settings: public health research priorities. Tropical Medicine and International Health 2005; 10: 295 – 299

233.Wolff B, Nyanzi B, Katongole G, Ssesanga D, Ruberantwari A, Whitworth J. Evaluation of a home-based VCT intervention in rural Uganda. Health Policy and Planning 2005; 20: 109-116.

232.  Nyanzi B, Nyanzi S, Wolff B, Whitworth J. Money, men and markets: Economic and sexual empowerment of market women in Southwestern Uganda. Culture, Health & Sexuality 2005; 7: 13-26.

231.   Korenromp R, White R, Orroth K, Bakker R, Kamali A, Serwadda D, Gray R, Grosskurth H, Habbema J, Hayes R. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: A synthesis of evidence from the Mwanza, Rakai and Masaka intervention trials. JID 2005; 191 (Supp 1): S 168 – 178

229. Kaleebu P, Elliot A, Whittle H: The immune response to infection. In: Parry E, Godfrey R, Mabey D, Gill G (Eds): Principles of Medicine in Africa. Cambridge University Press 2004, 3rd ed., 114 - 140

228. Grosskurth H, Brugha R, Foster S, Laing R: Management of a health service. In: Parry E, Godfrey R, Mabey D, Gill G (Eds): Principles of Medicine in Africa. Cambridge University Press 2004, 3rd ed., 87 - 110

227.  Campbell G, Pasquier E, Esquieu D, Watkins J, de Mareuil J, Braguer D, Kaleebu P, Yirrell D and Loret E. The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis.  J Biol Chem. 2004; 279: 48197-204.

226.  Viney ME, Brown M, Omoding NE, Bailey JW, Gardner MP, Roberts E, Morgan D, Elliott AM and Whitworth JAG. Why does HIV infection not lead to disseminated strongyloidiasis? Journal of Infectious Diseases 2004; 190: 2175-2180.

225.   White RG, Orroth KK, Korenromp EL, Bakker R, Wambura M, Sewankambo NK, Gray RH, Kamali A, Whitworth JA, Grosskurth H, Habbema JD, Hayes RJ. Can population differences explain the contrasting results of the Mwanza, Rakai and Masaka HIV/Sexually transmitted disease intervention trials?: A modeling study. Journal of AIDS 2004; 37: 1500-15

224.  Jacobs B, Whitworth J, Kambugu F and Pool R. STD management in Uganda’s private-for-profit formal and informal sector and compliance with treatment. Sexually Transmitted Diseases 2004; 31: 650-654.

223.  Quigley MA, Kamali A, Kinsman J, Kamulegeya I, Nakiyingi-Miiro J, Kiwuwa S, Kengeya-Kayondo JF, Carpenter LM and Whitworth JAG. The impact of attending a behavioural intervention on HIV incidence in Masaka, Uganda. AIDS 2004; 18: 2055-2063.

222. Senkaali D, Muwonge R, Morgan D, Whitworth JAG and Kaleebu P. The relationship between HIV-1 disease progression and V3 serotype in a rural Ugandan cohort. AIDS Research and Human Retroviruses 2004; 20: 932-937

221. Froebel K, Howard W, Schafer JR, Howie F, Whitworth J, Kaleebu P, Brown AL, and Riley E. Activation by malaria antigens renders mononuclear cells susceptible to HIV infection and re-activates replication of endogenous HIV in cells from HIV-infected adults. Parasite Immunology 2004; 26: 213-217.

220. Elliott AM, Hodsdon WS, Kyosiimire J, Quigley MA, Nakiyingi JS, Namujju PB, Watera C, French N, Gilks CF, Dockrell HM and Whitworth JAG. Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Transactions of the Royal Society of Tropical Medicine and Hygiene 2004; 98: 660-670

219. Opi S, Péloponèse JP, Esquieu D, Watkins J, Grant Campbell J, de Mareuil J, Jeang KT, Yirrell D, Kaleebu P and Loret E. Full-length HIV-1 Tat protein Necessary for a Vaccine. Vaccine 2004; 22: 3105-3111

218. Michael Brown. Is helminth infection associated with an increased rate of progression of HIV disease in Uganda? PhD Thesis 2004, University of London (234 pages).

217. Rutebemberwa A, Auma B, Gilmour J, Jones G, Yirrell D, Rowland S, Imami N, Watera C, Kaleebu P, Whitworth J and Gotch F.  HIV.1.specific inter and intra-Subtype cellular immune response in HIV.1.infected Ugandans. AIDS Research and Human Retroviruses 2004; 20: 763-771.

216. Elliott AM, Luzze H, Quigley MA, Nakiyingi JS, Kyaligonza S, Namujju PB, Ducar C, Ellner JJ, Whitworth JAG, Mugerwa R, Johnson JL and Okwera A. A randomised, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. Journal of Infectious Diseases 2004; 190: 869 – 878

215. Joseph S, Jones FM, Laidlaw ME, Mohammed G, Mawa PA, Namujju PB, Kizza M, Watera C, Whitworth JAG, Dunne DW, Elliott AM. Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 co-infection. Journal of Infectious Diseases 2004; 190: 613-618.

214. Schmidt GP, Buve A, Mugyenyi P, Garnett GP, Hayes RJ, Williams BG, Calleja JG, De Cock KM, Whitworth JA, Kapiga SH, Ghys PD, Hankins C, Zaba B, Heimer R, and Boerma JT. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004; 363: 482-488.

213. Eric S. Lugada. Affordable alternatives for managing HIV infected patients in a resource-poor country, Uganda. Doctoral thesis submitted in partial fulfilment of the requirements for a PhD. Centre for international Health, University of Bergen, Norway, 2004.

212. Brown M, Kizza M, Watera C, Quigley MA, Rowland S, Hughes P, Whitworth JAG and Elliott AM. Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. Journal of Infectious Diseases 2004; 190: 1869-1879.

211. Nyanzi S, Nyanzi B, Kalina B,  Pool P. Mobility, sexual networks and exchange among bodabodamenin southwest Uganda. Culture, Health and Sexuality 2004; 6: 239-254.

210.  Watera C, Nakiyingi J, Miiro G, Muwonge R, Whitworth JAG, Gilks CF, French N. 23-valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort. AIDS 2004; 18: 1210-1213.

209.  Jaffar S, Grant AD, Whitworth J, Smith PG, Whittle H. The natural history of HIV-1 and HIV-2 infections in adults in Africa. Bulletin of the World health organization 2004; 82: 462-469

208. Miiro G., French N. Management of adult pneumococcal disease:  Postgrad Doc Carribbean 2004: 20, 3-12.

207. Mawa PA, Pickering JM, Miiro G, Namujju PB, Watera CW, Anyaegani G, Whitworth JAG and Elliott AM. The effect of tuberculin skin testing on viral load and anti-mycobacterial immune responses in HIV-1-infected Ugandan adults. International Journal of Tuberculosis and Lung Diseases 2004; 8: 586-592.

206. Stanton T, Boxall S, Bennet A, Kaleebu P, Watera C, Whitworth J, Dawes R, Hill AVS, Bodmer W, Beverley PCL, Tchilian EZ. CD45 variant alleles: possibly increased frequency of a novel exon 4 CD45 polymorphism in HIV seropositive Ugandans. Immunogenetics (2004) 56:107-110.

205. Kebba A, Kaleebu P, Rowland S, Ingram R, Whitworth J, Imami N and Gotch F. Distinct patterns of peripheral HIV-1-specific interferon-γ responses in exposed HIV-1-seronegative individuals. Journal of Infectious Diseases 2004; 189: 1705-1713.

204. Pool R, Whitworth J and Muyinda H. Combating the spread of HIV/AIDS. Public Service Review: DFID an independent review. Summer 2004, 32-33.

203. Ross A, Van der Paal L, Lubega R, Mayanja BN, Shafer LA and Whitworth J. HIV-1 disease progression and fertility: the incidence of recognised pregnancy and pregnancy outcome in Uganda. AIDS 2004; 18: 799-804.

202.  Yirrell DL, Kaleebu P, Morgan D, Hutchinson S and Whitworth JA. HIV-1 subtype dynamics over 10 years in a rural Ugandan cohort. International Journal of STD & AIDS 2004; 15: 103-106.

201. Muyinda H, Nakuya J, Whitworth JAG and Pool R. Community sex education among adolescents in rural Uganda: utilizing indigenous institutions. AIDS Care 2004; 16: 69-79

200.  Bukusuba JW, Hughes P, Kizza M, Muhangi L, Muwanga M, Whitworth JAG and Elliott AM. Screening for intestinal helminth infection in a semi-urban cohort of pregnant women in Uganda. Tropical Doctor 2004; 34: 27-28.

199. Kebba A, Kaleebu P, Serwanga J, Rowland S, Yirrell D, Downing R, Gilmour J, Imami N, Gotch F and Whitworth J. HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV type 1 seronegative Ugandans. AIDS Research and Human Retroviruses 2004; 20: 67-75.

198.  Senkaali D, Muwonge R, Morgan D, Whitworth JAG and Kaleebu P. The relationship between HIV-1 disease progression and V3 serotype in a rural Ugandan cohort. AIDS Research and Human Retroviruses 2004; 20: 932-937

197.   Elliott AM, Kyosiimire J, Quigley M, Nakiyingi J, Watera C, Brown M, Joseph S, French N, Gilks C and Whitworth JAG. Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans. Transactions of the Royal Society of Tropical Medicine and Hygiene (2003) 97, 477-480.

196.  Todd J, Carpenter L, Li X, Nakiyingi J, Gray R, Hayes R: The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in Africa. International Journal  of Epidemiology 2003; 32: 755-762

195.  Nakiyingi JS, Bracher M, Whitworth JAG, Ruberantwari A, Busingye J, Mbulaiteye SM, Zaba B: Child survival in relation to mother’s HIV infection and survival: evidence from a Ugandan cohort study. AIDS 2003; 17: 1827-1834

194. Orroth KK, Korenromp EL, White RG, Gayvole A, Gray RH, Muhangi L, Sewankambo NK, Quigley M, Wawer MJ, Whitworth JAG, Grosskurth H, Habbema JDF and Hayes RJ. Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomes. AIDS 2003; 17: 2653- 2660. (copy on file is the proofs)

193.  Elliott AM, Mawa PA, Joseph S, Namujju PB, Kizza M, Nakiyingi JS, Watera C, Dunne DW and Whitworth JAG. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Transactions of the Royal Society of Tropical Medicine and Hygiene 2003; 97: 103-108.          

192. Mbulaiteye SM, Reeves BC, Mulwanyi F, Whitworth JAG and Johnson G. Incidence of visual loss in rural southwest Uganda. British Journal of Ophthalmology 2003; 87: 829-833.

191. Williams A. Ageing and poverty in Africa: Uganda livelihoods in a time of HIV/AIDS. Ashgate, Aldershot, 2003 [256 pages].

190.  Orroth KK, Korenromp EL, White RG, Changalucha J, de Vlas SJ, Gray RH, Hughes P, Kamali A, Ojwiya A, Serwadda D, Wawer MJ, Hayes RJ and Grosskurth H. Comparison of STD prevalences in the Mwanza, Rakai and Masaka trial populations: the role of selection bias and diagnostic errors. Sexually Transmitted Infections 2003; 79: 98-105.

189.  Ziegler J, Newton R, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, the Uganda Kaposi’s Sarcoma Study Group, Weiss R and Boshoff C. Risk factors for Kaposi’s sarcoma: a case-control study HIV-seronegative people in Uganda. International Journal of Cancer 2003; 103: 233-240.

188.  Newton R, Ziegler J, Bourboulia D, Casabonne D,  Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, the Uganda Kaposi’s Sarcoma Study Group, Weiss R and Boshoff C. The sero-epidemiology of Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. International Journal of Cancer 2003; 103: 226-232

187. Brown M, Bukusuba J, Hughes P, Nakiyingi J, Watera C, Elliott A and Whitworth J. Screening for intestinal helminth infestation in a semi-urban cohort of HIV-infected people in Uganda: a combination of techniques may enhance diagnostic yield in the absence of multiple stool samples. Tropical Doctor 2003; 33: 72-76.

186.  Cao H, Kaleebu P, Hom D, Flores J, Agrawal D, Jones N, Serwanga J, Okello M, Walker C, Sheppard H, El-Habib R, Klein M, Kebba A, Salata R, Mbidde E, Mugyenyi P, Walker B, Ellner J, Mugerwa R and the HIV Network for Prevention Trials. Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV network for prevention trials 007 vaccine study. Journal of Infectious Diseases 2003; 187: 887-895.

185.  Muyinda H, Nakuya J, Pool R and Whitworth J. Harnessing the senga institution of adolescent sex education for the control of HIV and STDs in rural Uganda. AIDS Care 2003; 15: 159-167.

184.  Jacobs B, Kambugu FSK, Whitworth JAG, Ochwo M, Pool R, Lwanga A, Tifft S, Lule J and Cutler JR. Social marketing of pre-packaged treatment for men with urethral discharge (Clear Seven) in Uganda. International Journal of STD & AIDS 2003; 14: 216-221.

183.  Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, Gopal R, Ojwiya A, Hughes P, Carpenter LM and Whitworth J. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomized trial. Lancet 2003; 361: 645-652.

182.  Jones G. The role and function of dendritic cells in HIV-1 infection with non-clade B HIV-1 isolates. PhD Thesis 2002, University of London (365 pages).

181. Mayanja BN, Kambugu FSK, Mbulaiteye SM and Whitworth JAG. Chronic facial crusts. Lancet 2002; 360: 1940.

180.  Rutebemberwa A. Characterisation of HIV-1 specific CD8+ T lymphocyte immune responses in HIV-1 infected Ugandan individuals. PhD Thesis 2002, University of London (338 pages).

179. Mbulaiteye SM, Mahe C, Whitworth JAG, Nakiyingi JS and Kamali A. HIV-1 incidence and prevalence trends in Uganda. Lancet 2002; 360: 1788-1789.

178.  Mahe C, Kaleebu P, Ojwiya A and Whitworth JAG. Human immunodeficiency virus type 1 Western blot: revised diagnostic criteria with fewer indeterminate results for epidemiological studies in Africa. International Journal of Epidemiology 2002; 31: 985-990.

177.  Kamali A, Kinsman J, Nalweyiso N, Mitchell K, Kanyesigye E, Kengeya-Kayondo JF, Carpenter LM, Nunn A and Whitworth JAG. A community randomized controlled trial to investigate impact of improved STD management and behavioural interventions on HIV incidence in rural Masaka, Uganda: trial design, methods and baseline findings. Tropical Medicine and International Health 2002; 7: 1053-1063.

176. Whitworth JAG, Mahe C, Mbulaiteye SM, Nakiyingi J, Ruberantwari A, Ojwiya A and Kamali A. HIV-1 epidemic trends in rural south-west Uganda over a 10-year period. Tropical Medicine and International Health 2002; 7: 1047-1052.

175.   Mbulaiteye SM, Mahe C, Ruberantwari A and Whitworth JAG. Generalizability of population-based studies on AIDS: a comparison of newly and continuously surveyed villages in rural southwest Uganda. International Journal of Epidemiology 2002; 36: 961-967.

174.  Newton R, Ziegler J, Ateenyi-Agaba C, Bousarghin L, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Bourboulia D, Boshoff C, Touze A, Coursaget P and the Uganda Kaposi's Sarcoma Study Group. The epidemiology of conjunctival squamous cell carcinoma in Uganda. British Journal of Cancer 2002; 87: 301-308.

173.   Brink A-K, Mahe C, Watera C, Lugada E, Gilks C, Whitworth J and French N. Diarrhoea, CD4 counts and enteric infections in a community-based cohort of HIV-infected adults in Uganda. Journal of Infection 2002; 45: 99-106.

172.  Mbulaiteye SM, Reeves B, Karabalinde A, Ruberantwari A, Mulwanyi F, Johnson G and Whitworth JAG. Evaluation of E optotypes as a screening test and the prevalence and causes of visual loss in a rural population in SW Uganda. Ophthalmic Epidemiology 2002; 9: 251-262.

171.  Opi S, Peloponese J-M Jr, Esquieu D, Campbell G, de Mareuil J, Walburger A, Solomiac M, Gregoire C, Bouveret E, Yirrell DL and Loret EP. Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants. Journal of Biological Chemistry 2002; 277: 35915-35919.

170.  Mbulaiteye SM, Mahe C, Whitworth JAG, Ruberwantari A, Nakiyingi JS, Ojwiya A and Kamali A. Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study. Lancet 2002; 360: 41-46.

169.  Corbett EL, Steketee RW, ter Kuile FO, Latif AS, Kamali A and Hayes RJ. HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet 2002; 359: 2177-2187.

168.  Mitchell K, Nakamanya S, Kamali A and Whitworth JAG. Exploring the community response to a randomized controlled HIV/AIDS intervention trial in rural Uganda. AIDS Education and Prevention 2002; 14: 207-216.

167.  The UNAIDS Reference Group on Estimates, Modelling and Projections. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact. Recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. AIDS 2002; 16: W1-W14.

166.  Kaleebu P. AIDS vaccine testing in Uganda. Suubi aids magazine 2002; 1: 36-37.

165. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, Nakiyingi J, Rutebemberwa A, Morgan D, Weber J, Gilks C and Whitworth J. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. Journal of Infectious Diseases 2002; 185:1244-1250.

164. Kinsman J, Kamali A, Kanyesigye E, Kamulegeya I, Bassajja V, Nakiyingi J, Schenk K and Whitworth J. Quantitative process evaluation of a community-based HIV/AIDS behavioural intervention in rural Uganda. Health Education Research 2002; 17: 253-265.

163. Ramaley PA, French N, Kaleebu P, Gilks C, Whitworth J and Hill AVS. Chemokine-receptor genes and AIDS risk. Nature 2002; 417: 140.

162.  French N, Gray K, Watera C, Nakiyingi J, Lugada E, Moore M, Lalloo D, Whitworth JAG and Gilks CF. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 2002; 16: 1031-1038.

161. Lugada ES, Watera C, Nakiyingi J, Elliott A, Brink A, Nanyunja M, French N, Antivelink L, Gilks C and Whitworth J. Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda. International Journal of Tuberculosis & Lung Disease 2002; 6: 326-331.

160. Whitworth J. Malaria and HIV. HIV InSite Knowledge Base Chapter, 2002. [http://hivinsite.ucsf.edu/insite.jsp?page=home-00-00£doc=kb-05-04-04]

159.  Mitchell K, Nakamanya S, Kamali A and Whitworth JAG. Balancing rigour and acceptability: the use of HIV incidence to evaluate a community-based randomised trial in rural Uganda. Social Science & Medicine 2002; 54: 1081-1091.

158.  Morgan D, Mahe C, Mayanja B and Whitworth JAG. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. British Medical Journal 2002; 324: 193-197.

157.  Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R and Whitworth JAG. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002; 16: 597-603.

156.   Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J and the WHO-UNAIDS Network for HIV Isolation and Characterization. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. Journal of AIDS 2002; 29:184-190.

155.  Carpenter LM, Kamali A, Payne M, Kiwuuwa S, Kintu P, Nakiyingi J, Kinsman J, Nalweyiso N, Quigley MA, Kengeya-Kayondo JF and Whitworth JAG. Independent effects of reported sexually transmitted infections and sexual behaviour on HIV-1 prevalence among adult women, men and teenagers in rural Uganda. Journal of AIDS 2002; 29: 174-180.

154.   Tchilian EZ, Dawes R, Ramaley PA, Whitworth JA, Yuldasheva N, Wells RS, Watera C, French N, Gilks CF, Kunachiwa W, Ruzibakiev R, Leetrakool N, Carrington CVF, Ramdath DD, Gotch F, Stephens HA, Hill AV and Beverley PCL. A CD45 polymorphism associated with abnormal splicing is absent in African populations. Immunogenetics 2002; 53: 980-983.

153. Yirrell DL, Kaleebu P, Morgan D, Watera C, Magambo B, Lyagoba F and Whitworth J. Inter- and intra-genic intersubtype HIV-1 recombination in rural and semi-urban Uganda. AIDS 2002; 16: 279-286.

152.  Mugerwa RD, Kaleebu P, Mugyenyi P, Katongole-Mbidde E, Hom DL, Byaruhanga R, Salata RA, Ellner JJ and the HIV-1 Vaccine Trial Group. First trial of the HIV-1 vaccine in Africa: Ugandan experience. British Medical Journal 2002; 324: 226-229.

151.  Gysels M, Pool R and Nnalusiba B. Women who sell sex in a Ugandan trading town: life histories, survival strategies and risk. Social Science & Medicine 2002; 54: 179-192.

150. Morgan D. Natural history of HIV-1 infection in adults in rural Uganda. MD Thesis 2001, University of Liverpool (238 pages).

149.  Williams A and Tumwekwase G. Multiple impacts of the HIV/AIDS epidemic on the aged in rural Uganda. Journal of Cross-Cultural Gerontology 2001; 16: 221-236.

148. McGrath JW, George K, Svilar G, Ihler E, Mafigiri D, Kabugo M and Mugisha E.  Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. Journal of AIDS 2001; 27: 381-388.

147. Polakow DA, Dunne TT and Whitworth JAG. Parameterisation of expected residual lifetime after seroconversion in a Ugandan sample population. South African Actuarial Journal 2001; 1: 35-61.

146. Pool R, Nyanzi S & Whitworth JAG. Attitudes to voluntary counselling and testing for HIV among pregnant women in rural south-west Uganda. AIDS Care 2001; 13: 605-615.

145.  Pool R. Palliatieve zorg in zuidwest Oeganda. Pallium 2001;  Februari/Maart: 22-25.

144. Morgan D, Mahe C, Okongo M, Mayanja B and Whitworth JAG. Genital ulceration in rural Uganda: sexual activity, treatment-seeking behavior, and the implications for HIV control. Sexually Transmitted Diseases 2001; 28: 431-436.

143.  Morgan D, Mahe C and Whitworth J. Absence of a recognizable seroconversion illness in Africans infected with HIV-1. AIDS 2001; 15: 1575-1576.

142. Muyinda H, Kengeya J, Pool R and Whitworth J. Traditional sex counselling and STI/HIV prevention among young women in rural Uganda. Culture, Health & Sexuality 2001; 3: 353-361.

141.  Jones GJ, Watera C, Patterson S, Rutebemberwa A, Kaleebu P, Whitworth JA, Gotch FM and Gilmour JW. Comparative loss and maturation of peripheral blood dendritic cell subpopulations in African and non-African HIV-1-infected patients. AIDS 2001; 15: 1657-1664.

140. Kamali A, Kinsman J, Kintu P, Quigley M, Carpenter L, Kengeya-Kayondo J and Whitworth JAG. A community randomised trial (CRT) to evaluate impact of behavioural intervention, with or without syndromic STD management, on incidence of HIV and other STDs in rural Uganda. Journal of Epidemiology & Community Health 2001; 55 (suppl 1): A27.

139. Whitworth J. Time for universal rules for a fair trial. Times Higher Education Supplement, August 31st 2001, 22-23.

138. Mitchell K, Nakamanya S, Kamali A and Whitworth JAG. Community-based HIV/AIDS education in rural Uganda: which channel is most effective? Health Education Research 2001; 16: 411-423.

137. Luzze H, Elliott AM, Joloba ML, Odida ML, Oweka-Onyee J, Nakiyingi J, Quigley M, Hirsch C, Mugerwa RD, Okwera A and Johnson JL. Evaluation of suspected tuberculous pleurisy: clinical and diagnostic findings in HIV-1-positive and HIV-negative adults in Uganda. International Journal of Tuberculosis & Lung Disease 2001; 5: 746-753.

136.  Nalweyiso N, Kasse M, Kamali A, Kintu P and Whitworth J. Self-reported cure rates among STD patients at government health units (HUs) in Uganda and why patients do not return for follow-up review. International Journal of STD & AIDS 2001, 12 ( suppl 1): 211.

135.  Orroth KK, Korenromp EL, White RG, Kamali A, Serwadda D, Sewankambo NK, Whitworth JAG, Grosskurth H, Habbema JDF and Hayes RJ. Higher risk behaviours and STD rates in Tanzania compared to Uganda – contribution to different outcomes of STD treatment trials? International Journal of STD & AIDS 2001, 12 (suppl 1): 172.

134.   Kamali A, Kintu P, Nalweyiso N, Kinsman J and Whitworth J. A randomised controlled trial (RCT) of syndromic STD management and behavioural change interventions to reduce HIV infection in rural Uganda. International Journal of STD & AIDS 2001, 12 (suppl 1): 46-47.

133. Pool R, Nyanzi S and Whitworth JAG. Breast feeding practices and attitudes relevant to the vertical transmission of HIV in rural south-west Uganda. Annals of Tropical Paediatrics 2001; 21: 119-125.

132.  Walker D, Muyinda H, Foster S, Kengeya-Kayondo J and Whitworth J. The quality of care by private practitioners for sexually transmitted diseases in Uganda. Health Policy & Planning 2001; 16: 35-40.

131.  French N, Nakiyingi J, Lugada E, Watera C, Whitworth JAG and Gilks CF. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 2001; 15: 899-906.

130.  Gysels M, Pool R and Bwanika K. Truck drivers, middlemen and commercial sex workers: AIDS and the mediation of sex in south west Uganda. AIDS Care 2001; 13: 373-385.

129. Hodsdon WS, Luzze H, Hurst TJ, Quigley MA, Kyosiimire J, Namujja PB, Johnson JL, Kaleebu P, Okwera A and Elliott AM. HIV-1-related pleural tuberculosis: elevated production of IFN-g, but failure of immunity to Mycobacterium  tuberculosis. AIDS 2001; 15: 467-475.

128.  Newton R, Ziegler J, Beral V, Mbidde E, Carpenter L, Wabinga H, Mbulaiteye S, Appleby P, Reeves G, Jaffe H and the Uganda Kaposi’s Sarcoma Study Group. A case-control study of Human Immunodeficiency Virus infection and cancer in adults and children residing in Kampala, Uganda. International Journal of Cancer 2001; 92: 622-627.

127.  Kinsman J, Nakiyingi J, Kamali A and Whitworth J. Condom awareness and intended use: gender and religious contrasts among school pupils in rural Masaka, Uganda. AIDS Care 2001; 13: 215-220.

126. Pool R, Whitworth J, Green G, Mbonye A, Harrison S, Hart G and Wilkinson J. Ambiguity, sexual pleasure and the acceptability of microbicidal products in southwest Uganda. AIDS 2001; 15 (suppl 1): S30-S31.

125.  Morgan D, Mahe C, Malamba S, Okongo M, Mayanja B and Whitworth J. Herpes zoster and HIV-1 infection in a rural Ugandan cohort. AIDS 2001; 15: 223-229.

124.  McGrath JW, Mafigiri D, Kamya M, George K, Senvewo R, Svillar G, Kabugo M and Mushiga E. Developing AIDS vaccine trials educational programs in Uganda. Journal of AIDS 2001; 26: 176-181.

123. Kinsman J, Nakiyngi J, Kamali A, Carpenter L, Quigley M, Pool R and Whitworth J. Evaluation of a comprehensive school-based AIDS education programme in rural Masaka, Uganda. Health Education Research 2001; 16: 85-100.

122. Morgan D, Kaleebu P, Whitworth J, Yirrell D, Rutebemberwa A, Shier R, Sebabi B, Gilmour J, Eotu H, Omoding N and Gotch F. The stability between two HIV-1 RNA levels measurements one year apart and the relationship with HIV subtype in rural Uganda. International Journal of STDs & AIDS 2001;12: 116-121.

121. Nyanzi S, Pool R and Kinsman J. The negotiation of sexual relationships among school pupils in south-western Uganda. AIDS Care 2001; 13: 83-98.

120.  Kaleebu P, Ross A, Morgan D, Yirrell D, Oram J, Rutebemberwa A, Lyagoba F, Hamilton L, Biryahwaho B and Whitworth J. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS 2001; 15: 293-299.

119.  Whitworth J, Morgan D and Quigley M. HIV-1 infection and malaria parasitaemia. Lancet 2001; 357: 232-233.

118.  Morgan D and Whitworth JAG. The natural history of HIV-1 infection in Africa. Nature Medicine 2001; 7: 143-145.

117. Green G, Pool R, Harrison S, Hart GJ, Wilkinson J, Nyanzi S and Whitworth JAG. Female control of sexuality: illusion or reality? Use of vaginal products in southwest Uganda. Social Science & Medicine 2001; 52: 585-598.

116.  Lara-Peredo O, Cuevas LE, French N, Bailey JW and Smith DH. Cryptococcal infection in an HIV-positive Ugandan population. Journal of Infection 2000; 41: 195.

115. Ramaley PA. Host genetics of HIV-1 infection and disease progression in Uganda. DPhil Thesis, Oxford University 2000 (245 pages).

114. Anderson TJC, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, Mollinedo R, Bockarie M, Mokili J, Mharakurwa S, French N, Whitworth J, Velez ID, Brockman AH, Nosten F, Ferriera MU and Day KP. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Molecular Biology & Evolution 2000; 17: 1467-1482.

113. Gray KJ, French N, Lugada E, Watera C and Gilks CF. Rhodococcus equi and HIV-1 infection in Uganda. Journal of Infection 2000; 41: 227-231.

112.  Mitchell K and Branigan P. Using focus groups to evaluate health promotion interventions. Health Education 2000; 100: 261-268.

111. French N and Gilks CF. Pneumococcal vaccine and HIV-1 infection. Lancet 2000; 356: 1272-1273.

110. Williams A. Old age in contemporary Buganda. PhD thesis, University of Queensland, Australia 2000 (339 pages).

109.  Zaba BW, Carpenter LM, Boerma JT, Gregson S, Nakiyingi J and Urassa M. Adjusting ante-natal clinic data for improved estimates of HIV prevalence among women in sub-Saharan Africa. AIDS 2000; 14: 2741-2750.

108. Mbulaiteye SM, Ruberantwari A, Nakiyingi JS, Carpenter LM, Kamali A and Whitworth JAG. Alcohol and HIV: a study among sexually active adults in rural south west Uganda. International Journal of Epidemiology 2000; 29: 911-915.

107.  French N and Gilks CF. HIV and malaria, do they interact? Transactions of the Royal Society of Tropical Medicine & Hygiene 2000; 94: 233-237.

106.  Gopal R, Gibbs T, Slomka MJ, Whitworth J, Carpenter LM, Vyse A and Brown DW. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa. Journal of Virological Methods 2000; 87: 71-80.

105. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, Omoding N, Okongo M, Malamba S and Ojwiya A. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000; 356: 1051-1056. [Department of Error – Lancet 2000; 356: 2016]

104. Pool R, Whitworth JAG, Green G, Mbonye AK, Harrison S, Hart GJ and Wilkinson J. Ambivalence, sexual pleasure and the acceptability of microbicidal products in south-west Uganda. AIDS 2000; 14: 2058-2059.

103.  Gotch F, Rutebemberwa A, Jones G, Imami N, Gilmour J, Kaleebu P and Whitworth J. Vaccines for the control of HIV/AIDS. Tropical Medicine & International Health 2000; 5: A16-A21.

102.  Pool R. Whitworth JAG, Green G, Mbonye AK, Harrison S, Wilkinson J and Hart GJ. An acceptability study of female-controlled methods of protection against HIV and STDs in south-western Uganda. International Journal of STD & AIDS 2000; 11: 162-167.

101. Kinsman J, Kamali A and Whitworth J. Statistical methods and the evaluation of school-based AIDS education in Africa. International Journal of STDs & AIDS 2000; 11: 553.

100. Morgan D, Malamba SS, Orem J, Mayanja B, Okongo M and Whitworth JAG. Survival by AIDS defining condition in rural Uganda. Sexually Transmitted Infections 2000; 76: 193-197.

99. French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, Whitworth J and Gilks CF. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000; 355: 2106-2111.

98. Kaleebu P, Yirrell D, French N, Lyagoba F, Rutebemberwa A, Cheingsong-Popov R, Gilks C, Biryahwaho B, Weber J and Whitworth J. An improved algorithm for determining HIV Type 1 subtypes in a primary laboratory in Uganda. AIDS Research & Human Retrovirology 2000; 16: 621-625.

97. Quigley MA, Morgan D, Malamba SS, Mayanja B, Okongo MJ, Carpenter LM and Whitworth JA. Case-control study of risk factors for incident HIV infection in rural Uganda. Journal of AIDS 2000; 23: 418-425.

96. Kinsman J. Reflections on a school-based AIDS education programme in rural Masaka, Uganda. SAfAIDS News 2000; 8:13-15.

95.  Pool R, Hart G, Green G, Harrison S, Nyanzi S and Whitworth J. Men's attitudes to condoms and female controlled means of protection against HIV and STDs in south-western Uganda. Culture, Health & Sexuality 2000; 2: 197-212.

94.  Kinsman J, Nyanzi S and Pool R. Socialising influences and value of sex: the experience of adolescent school girls in rural Masaka, Uganda. Culture, Health & Sexuality 2000; 2: 151-166.

93. Kaleebu P, Whitworth J, Hamilton L, Rutebemberwa A, Lyagoba F, Morgan D, Duffield M, Biryahwaho B, Magambo B and Oram J. Molecular epidemiology of HIV Type 1 in a rural community in southwest Uganda. AIDS Research & Human Retroviruses 2000; 16: 393-401.

92.  Kamali A, Carpenter LM, Whitworth JAG, Pool R, Ruberantwari A and Ojwiya A. Seven-year trends in HIV-1 infection rates, and changes in sexual behaviour, among adults in rural Uganda. AIDS 2000; 14: 427-434.

91.  Krausa P, McAdam S, Bunce M, Whitworth J, Biryahwaho B, French N, Tugume B, Gilks C and Gotch F. HLA-A, -B, -C, -DRB1, DRB3, DRB4, DRB5 and DQB1 polymorphism detected by PCR-SSP in a semi-urban HIV-positive Ugandan population. Experimental & Clinical Immunogenetics 1999; 16: 17-25.

90. Morgan D, Jones C, Whitworth J, Ross A and Johnson G. Ocular findings of HIV-1 positive and HIV-1 negative participants in a rural population-based cohort in Uganda. International Ophthalmology 1999; 22: 183-192.

89.  French N, Mujugira A, Nakiyingi J, Mulder D, Janoff EN and Gilks CF. Immunologic and clinical stages in HIV-1 infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease. Journal of AIDS 1999; 22: 509-516.

88.  Malamba SS, Morgan D, Clayton T, Mayanja B, Okongo M and Whitworth J. The prognostic value of the World Health Organisation staging system for HIV infection and disease in rural Uganda. AIDS 1999; 13: 2555-2562.

87.  Hart GJ, Pool R, Green G, Harrison S, Nyanzi S and Whitworth JAG. Women's attitudes to condoms and female-controlled means of protection against HIV and STDs in South-Western Uganda. AIDS Care 1999; 11: 687-698.

86. Morgan D, Rutebemberwa A, Malamba S, Ross A, Whitworth J, Kaleebu P and Gotch F. HIV-1 RNA levels in an African population-based cohort and their relation to CD4 lymphocyte counts and World Health Organization clinical staging. Journal of AIDS 1999; 22: 167-173.

85.  Kengeya-Kayondo JF, Carpenter LM, Kintu PM, Nabaitu J, Pool R and Whitworth JAG. Risk perception and HIV-1 prevalence in 15,000 adults in rural south-west Uganda. AIDS 1999; 13: 2295-2302.

84.  Robinson NJ, Mulder D, Auvert B, Whitworth J and Hayes R. Type of partnership and heterosexual spread of HIV infection in rural Uganda: results from simulation modelling. International Journal of STD & AIDS 1999; 10: 718-725.

83. Whitworth JAG. Medical Research Council Programme on AIDS in Uganda – the first 10 years. Interdisciplinary Science Reviews 1999; 24: 179-184.

82.  Ross A, Morgan D, Lubega R, Carpenter LM, Mayanja B and Whitworth JAG. Reduced fertility associated with HIV: the contribution of pre-existing subfertility. AIDS 1999; 13: 2133-2141.

81.  Kinsman J, Harrison S, Kengeya-Kayondo J, Kanyesigye E, Musoke S and Whitworth J. Implementation of a comprehensive school-based AIDS education programme in Masaka District, Uganda. AIDS Care 1999; 11: 591-601.

80.  Elliott AM, Nakiyingi J, Quigley MA, French N, Gilks C and Whitworth JAG. Inverse association between BCG immunisation and intestinal nematode infestation among HIV-1-positive individuals in Uganda. Lancet 1999; 354: 1000-1001.

79.   Huygens P. Mode et sexualité : la "bonne conduite" à l'épreuve de la mode chez les adolescents du Buganda. In ‘Vivre et penser le sida en Afrique / Experiencing and understanding AIDS in Africa’ Becker C, Dozon J-P, Obbo C and Touré M (éds). Codesria, IRD, Karthala, Paris 1999, pp 405-418.

78.  Pool R. Acceptability of the female condom and vaginal spermicidal products in Uganda. Sexual Health Exchange 1999 (1): 5-7.

77.  Whitworth J, Pickering H, Mulwanyi F, Ruberantwari A, Dolin P and Johnson G. Determinants of attendance and patient satisfaction at eye clinics in south-western Uganda. Health Policy & Planning 1999; 14: 77-81.

76. Kamali A, Whitworth JAG, Ruberantwari A, Mulwanyi F, Acakara M, Dolin P and Johnson G. Causes and prevalence of non-vision impairing ocular conditions among a rural adult population in SW Uganda. Ophthalmic Epidemiology 1999; 6: 41-48.

75.   Mayanja B, Morgan D, Ross A and Whitworth J. The burden of mucocutaneous conditions and the association with HIV-1 infection in a rural community in Uganda. Tropical Medicine & International Health 1999; 4: 349-354.

74.   Carpenter LM, Kamali A, Ruberantwari A, Malamba SS and Whitworth JAG. Rates of HIV-1 transmission within marriage in rural Uganda in relation to the HIV sero-status of the partners. AIDS 1999; 13: 1083-1089.

73. Williams A and Tumwekwase G. “An elephant has to carry its tusks: grandparents’ efforts to educate their grandchildren in rural Uganda.” in Education for sustainable development: getting it right, Eds. Thomas P &  Bissell S, Development Studies Network, Australian National University, Canberra, 1999, 51-57.

72. Kamali A, Nunn AJ, Mulder DW, Van Dyck E, Dobbins JG and Whitworth JAG. Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sexually Transmitted Infections 1999; 75: 98-102.

71.  Elliott AM, Hurst TJ, Balyeku MN, Quigley MA, Kaleebu P, French N, Biryahwaho B, Whitworth JAG, Dockrell HM and Hayes RJ. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study. International Journal of Tuberculosis & Lung Disease 1999; 3: 239-247.

70.  McAdam S, Kaleebu P, Krausa P, Goulder P, French N, Collin B, Blanchard T, Whitworth J, McMichael A and Gotch F. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS 1998; 12: 571-579.

69.  French N, Gilks CF, Mujugira A, Fasching C, O'Brien J and Janoff EN. Pneumococcal vaccination in HIV-1 infected adults in Uganda: humoral response and two vaccine failures. AIDS 1998; 12: 1683-1689.

68.   Yirrell DL, Pickering H, Palmarini G, Hamilton L, Rutemberwa A, Biryahwaho B, Whitworth J and Leigh Brown AJ. Molecular epidemiological analysis of HIV in sexual networks in Uganda. AIDS 1998; 12: 285-290.

67.  Okongo M, Morgan D, Mayanja D, Ross A and Whitworth J. Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. International Journal of Epidemiology 1998; 27: 698-702.

66.  Boerma JT, Nunn AJ and Whitworth JAG. Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries. AIDS 1998; 12 (suppl 1): S3-S14.

65.  Morgan D, Ross A, Mayanja B, Malamba S and Whitworth J. Early manifestations (pre-AIDS) of HIV-1 infection in Uganda. AIDS 1998; 12: 591-596.

64. Pickering H, Okongo M, Bwanika K, Nnaluusiba B and Whitworth J. Sexual behaviour in a fishing community on Lake Victoria, Uganda. Health Transition Review 1997; 7: 13-20.

63.  Pickering H, Okongo M, Bwanika K, Nnaluusiba B and Whitworth J. Sexual networks in Uganda: casual and commercial sex in a trading town. AIDS Care 1997; 9: 199-207.

62. Hayes R, Wawer M, Gray R, Whitworth J, Grosskurth H, Mabey D and HIV/STD Trials Workshop Group. Randomised trials of STD treatment for HIV prevention: report of an international workshop. Genitourinary Medicine 1997; 73: 432-443.

61.   Ali S. Host genetic susceptibility to HIV in a rural Ugandan population. DPhil Thesis, Oxford University, 1997 (244 pages).

60. Morgan D, Whitworth JAG, Ross A, Omoding N and Eotu H. Fever in Africa and WHO recommendation. Lancet 1997; 350: 1549-1550.

59.  Aaby P and 38 others (including Kaleebu P, Kengeya-Kayondo J, Whitworth J). Ethics of HIV trials. Lancet 1997; 350: 1546.

58. Carpenter LM, Nakiyingi JS, Ruberantwari A, Malamba SS, Kamali A and Whitworth JAG. Estimates of the impact of HIV infection on fertility in a rural Ugandan population cohort. Health Transition Review 1997; 7 (suppl 2): 113-126.

57.  French N, Mpiirwe B, Namara AH and Kyalo G. HIV testing strategies at a community clinic in Uganda. AIDS 1997; 11: 1779.

56.   Nunn AJ, Mulder DW, Kamali A, Ruberantwari A, Kengeya-Kayondo J-F and Whitworth J. Mortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study. British Medical Journal 1997; 315: 767-771.

55.  Whitworth J. Tackling STDs in a bid to halt HIV. MRC News 1997; 75: 34-37.

54.  Morgan D, Malamba SS, Maude GH, Okongo MJ, Wagner H-U, Mulder DW and Whitworth JA. An HIV-1 natural history cohort and survival times in rural Uganda. AIDS 1997; 11: 633-640.

53.  Muyinda H, Seeley J, Pickering H and Barton T. Social aspects of AIDS-related stigma in rural Uganda. Health & Place 1997; 3: 143-147.

52.   Robinson NJ, Mulder DW, Auvert B and Hayes RJ. Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population: simulation model estimates. International Journal of Epidemiology 1997; 26: 180-189.

51. Pickering H, Okongo M, Ojwiya A, Yirrell D and Whitworth J. Sexual networks in Uganda: mixing patterns between a trading town, its rural hinterland and a nearby fishing village. International Journal of STD & AIDS 1997; 8: 495-500. [Corrigendum - International Journal of STD & AIDS 1998; 9: 430]

50.  Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner H-U, Mulder DW and Whitworth JA. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997; 350: 245-250.

49. Pickering H and Nunn AJ. A three-year follow-up survey of demographic changes in a Ugandan town on the trans-African highway with high HIV-1 seroprevalence. Health Transition Review 1997; 7 (suppl 1): 41-47.

48.  Huygens P, Kajura E, Seeley JA and Barton T. Rethinking methods for the study of sexual behaviour. Social Science & Medicine 1996; 42: 221-231.

47. Mulder D. "Disease progression and mortality following HIV-1 infection" in AIDS in the World, Eds. J Mann & D Tarantola, 2nd Ed., Oxford University Press, New York 1996, 15-17.

46.  Balmer DH, Seeley J and Bachengana C. The role of counselling in community support for HIV/AIDS in Uganda. Counselling Psychology Quarterly 1996; 9: 177-190.

45. Kengeya-Kayondo JF, Kamali A, Nunn AJ, Ruberantwari A, Wagner H-U and Mulder DW. Incidence of HIV-1 infection in adults and socio-demographic characteristics of seroconverters in a rural population in Uganda: 1990-1994. International Journal of Epidemiology 1996; 25: 1077-1082.

44. Kengeya-Kayondo JF. Strategies for HIV/AIDS control in adults in sub-Saharan Africa. Journal of Epidemiology 1996; 6: S121-S123.

43.  Maude GH, Whitworth JAG and Pool R. Prevention of HIV spread in developing countries. Lancet 1996; 348: 1742-1743.

42.  Pickering H, Kajura E, Katongole G and Whitworth J. Women's groups and individual entrepreneurs: a Ugandan case study. Gender & Development 1996; 4: 54-60.

41. Kamali A, Seeley JA, Nunn AJ, Kengeya-Kayondo JF, Ruberantwari A and Mulder DW. The orphan problem: experience of a sub-Saharan Africa rural population in the AIDS epidemic. AIDS Care 1996; 8: 509-515.

40.  Bunnell RE. Promoting or paralyzing behavior change: understanding gender and high levels of perceived risk of HIV infections in southwestern Uganda. PhD Thesis, Harvard School of Public Health, Boston 1996 (244 pages).

39.  Morgan D, Whitworth J, Eotu H, Omoding N and Moore M. Gastrointestinal parasite infections. Lancet 1996; 348: 965-966.

38. Nunn AJ, Mulder DW, Kamali A, Kengeya-Kayondo J-F and Whitworth JAG. HIV-1 incidence in sub-Saharan Africa. Lancet 1996; 348: 833-834.

37. Mulder DW. The epidemiology of HIV-1 in a rural Ugandan population. PhD Thesis, Erasmus University, Rotterdam 1996 (152 pages).

36.   Kamali A, Wagner HU, Nakiyingi J, Sabiiti I, Kengeya-Kayondo JF and Mulder DW. Verbal autopsy as a tool for diagnosing HIV-related adult deaths in rural Uganda. International Journal of Epidemiology 1996; 25: 679-684.

35.  Nunn A. La seroprevalence est-elle en voie de stabilisation en Ouganda? Le Journal du sida 1996; 86-87: 17-18.

34. Taylor L, Seeley J and Bajenja EK. Informal care for illness in rural southwest Uganda: the central role that women play. Health Transition Review 1996; 6: 49-56.

33. Pickering H, Okongo M, Bwanika K, Nnalusiba B and Whitworth J. Sexual mixing patterns in Uganda: small-time urban/rural traders. AIDS 1996; 10: 533-536.

32.  Nunn AJ, Wagner HU, Okongo JM, Malamba SS, Kengeya-Kayondo JF and Mulder DW. HIV-1 infection in a Ugandan town on the trans-African highway: prevalence and risk factors. International Journal of STD & AIDS 1996; 7: 123-130.

31. Whitworth J, Pickering H and Morgan D. Disclosing HIV status to partners. Lancet 1996; 347: 973.

30. Mulder DW, Nunn A, Kamali A and Kengeya-Kayondo JF. Post-natal incidence of HIV-1 infection among children in a rural Ugandan population: no evidence for transmission other than mother to child. Tropical Medicine & International Health 1996; 1: 81-85.

29.  French N. Financial hijacking of conferences. Lancet 1996; 347: 1119-1120.

28. Seeley J, Nabaitu J, Taylor L, Kajura E, Bukenya T, Kabunga E and Ssembajja F. Revealing gender differences through well-being ranking in Uganda. PLA Notes 1996: 25: 14-18.

27. Nunn AJ, Wagner HU, Kamali A, Kengeya-Kayondo JF and Mulder DW. Migration and HIV-1 seroprevalence in a rural Ugandan population. AIDS 1995; 9: 503-506.

26. Seeley JA, Kajura E and Mulder DW. Methods used to study household coping strategies in rural south west Uganda. Health Policy & Planning 1995; 10: 79-88.

25.  Kengeya-Kayondo JF, Malamba SS, Nunn AJ, Seeley JA, Ssali A and Mulder DW. Human immunodeficiency virus (HIV-1) seropositivity among children in a rural population of south-west Uganda: probable routes of exposure. Annals of Tropical Paediatrics 1995; 15: 115-120.

24. Robinson NJ, Mulder DW, Auvert B and Hayes RJ. Modelling the impact of alternative HIV intervention strategies in rural Uganda. AIDS 1995; 9: 1263-1270.

23.  Seeley J and Kajura EB. Grief and the community. In: "Grief and AIDS", ed. L. Sherr; J. Wiley and Sons, Sussex. 1995, pp 73-85.

22.  Mulder D, Nunn A, Kamali A and Kengeya-Kayondo J. Decreasing HIV-1 seroprevalence in young adults in a rural Ugandan cohort. British Medical Journal 1995; 311: 833-836.

21. Robinson NJ. The association of HIV-1 and other sexually transmitted diseases, and its relevance to intervention programmes in rural Uganda: a simulation modelling exercise. PhD Thesis 1994, London School of Hygiene and Tropical Medicine, University of London (220 pages).

20. Mulder DW. Disease perception and health seeking behaviour for sexually transmitted diseases. In: Prevention and Management of Sexually Transmitted Diseases in Eastern and Southern Africa: Current Approaches and Future Directions. Proceedings of NARESA Monograph No. 3, Network of AIDS Researchers of Eastern and Southern Africa, Nairobi, 1994, pp 83-89.

19.  Robinson NJ, Auvert B, Mulder DW and Hayes RJ. Home testing for HIV. Lancet 1994; 343: 1294. 

18. Mulder DW, Nunn AJ, Wagner HU, Kamali A and Kengeya-Kayondo JF. HIV-1 incidence and HIV-1 associated mortality in a rural Ugandan population cohort. AIDS 1994; 8: 87-92.

17.  Nabaitu J, Bachengana C and Seeley J. Marital instability in a rural population in south west Uganda: implications for the spread of HIV-1 infection. Africa 1994; 64: 243-251.

16. Wagner HU, Van Dyck E, Roggen E, Nunn AJ, Kamali A, Scott Schmid D, Dobbins JG and Mulder DW. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan Population. International Journal of STD & AIDS 1994; 5: 332-337.

15. Seeley JA, Malamba SS, Nunn AJ, Mulder DW, Kengeya-Kayondo JF and Barton T. Socio economic status, gender and risk of HIV-1 infection in a rural community in south west Uganda. Medical Anthropology Quarterly 1994; 8: 78-89.

14.  Kengeya-Kayondo JF, Seeley JA, Kajura-Bajenja E, Kabunga E, Mubiru E, Sembajja F and Mulder DW. Recognition, treatment seeking behaviour and perception of cause of malaria among rural women in Uganda. Acta Tropica 1994; 58: 267-273.

13. Kengeya-Kayondo JF. Transdisciplinary research: research capacity building in developing countries at low cost. Acta Tropica 1994; 57: 147-152.

12. Mulder DW, Nunn AJ, Kamali A, Nakiyingi J, Wagner HU and Kengeya-Kayondo JF. Two-year HIV-1-associated mortality in a Ugandan rural population. Lancet 1994; 343: 1021-1023.

11. Malamba SS, Wagner HU, Maude G, Okongo M, Nunn AJ, Kengeya-Kayondo JF and Mulder DW. Risk factors for HIV-1 infection in a rural Ugandan community: a case-control study. AIDS 1994; 8: 253-257.

10. Nunn AJ, Downing R, Biryahwaho B, Ojwiya A and Mulder DW. Computer-assisted quality assurance in an HIV-1 serology laboratory. Methods of Information in Medicine 1994, 33: 170-173.

9.  Nunn AJ, Kengeya-Kayondo JF, Malamba S, Seeley JA and Mulder DW. Risk factors for HIV-1 infection in adults in a rural Ugandan community: a population study. AIDS 1994; 8: 81-86.

8. Mulder DW and Smith PG. AIDS in Africa - HIV is having a profound impact. British Medical Journal 1993; 306: 1691.

7.  Seeley JA. Searching for indicators of vulnerability: a study of household coping strategies in rural south west Uganda. Mimeograph, 1993, (252 pages).

6. Wagner HU, Kamali A, Nunn AJ, Kengeya-Kayondo JF and Mulder DW. General and HIV-1 associated morbidity in a rural Ugandan community. AIDS 1993; 7: 1461-1467.

5. Nunn AJ, Biryahwaho B, Downing RG, Groen G van der, Ojwiya A and Mulder DW. Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort. AIDS 1993; 7: 1057-1061.

4. Robinson NJ, Hayes R and Mulder D. Using condoms to prevent transmission of HIV. British Medical Journal 1993; 307: 1007.

3. Seeley JA, Kajura E, Bachengana C, Okongo M, Wagner U and Mulder DW. The extended family and support for people with AIDS in a rural population in south west Uganda: a safety net with holes? AIDS Care 1993; 5: 117-122.

2. Seeley JA, Kengeya-Kayondo JF and Mulder DW. Community-based HIV/AIDS research - whither community participation? Unsolved problems in a research programme in rural Uganda. Social Science & Medicine 1992; 34: 1089-1095.

1. Seeley J, Wagner U, Mulemwa J, Kengeya-Kayondo JF and Mulder DW. The development of a community based HIV/AIDS service in a rural area of Uganda. AIDS Care 1991; 3: 207-217.